Compare Sana Biotechnology Inc (SANA) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Stryker Corporation — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Stryker Corporation trades at $314.62 (market cap $122.35B). The key difference: Stryker Corporation is far larger — about 140× Sana Biotechnology Inc's market cap, and Stryker Corporation pays a 1% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | SYK | |
|---|---|---|
Market Cap | $873.84M | $122.35B |
Sector | Health | Technology |
52-Week High | $5.92 | $403.53 |
52-Week Low | $2.68 | $282.58 |
Enterprise Value | $848.03M | $134.10B |
Dividend Yield | — | 1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
